7th CB Conversion Price Adjusted (KRW 4,100 → 3,522)


  • Conversion price of 7th unlisted CB adjusted downward from KRW 4,100 to 3,522 due to market price decline (effective 2026-05-11).
  • Number of convertible shares increased from 121,951 to 141,964 (increase of 20,013 shares).
  • 5:1 stock split effective April 16, 2026, resulting in par value of KRW 500 and adjusted floor/ceiling limits.
  • This is a periodic monthly adjustment based on market price, with a floor at par value of KRW 500.
ADVERTISEMENT (250px+)

KOSDAQ Filing Information


  • Filing: Conversion Price Adjustment
  • Company: Kyung Nam Pharm (053950)
  • Submission: Kyung Nam Pharm Co., Ltd.
  • Receipt: 05-11-2026
  • Under KRX KOSDAQ Market Division